Orthobiology
is a branch of science that develops bone and tissue replacement
materials for fasthealing and quick recovery of injured muscles,
broken bones, ligaments and tendons. Orthobiologics is considered as
a highly lucrative market owing to significant growth opportunities.
One of the major driver for the growth of this industry is certain
limitations that are associated with autografts and allografts.
Although, autografts are considered as gold standard for orthopedic
procedures but the usage of autograft involves donor site morbidity
and an additional surgery. While, the major concerns associated with
allografts is risk of disease transmission along with the decline in
theiravailability. Therefore, in order to overcome these drawbacks of
the autografts and allografts, bone graft substitutes are being
preferred for use in orthopaedic surgery.
According
to the American Academy of Orthopedic Surgeons (AAOS), approximately
465,000 spinal surgeries were performed in the U.S in 2011. Of all
the spinal fusion surgeries performed, 46% were for lumbar fusion,
42% were for cervical fusion and the remaining 13% were for thoracic
or multi-level fusion procedures. This rise in number of spinal
fusion surgeries has created the demand for bone graft substitutes
and has consequently boosted the overall growth of this industry. In
addition, rise in the incidence of arthritis, increase in geriatric
population and increase in obesity rate has triggered the growth of
this market. Technological advancements, growing demand for minimally
invasive procedures and rising patient awareness are the other
factors that has considerably augmented the growth of this market.
The global orthobiologics market was valued at USD 3,754.6 million in
2012 and is expected to grow at a CAGR of 5.9%from 2013 to 2019 to
reach at an estimated value of USD 5,519.9 million in 2019.
Download
Complete PDF
Brochure:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1747
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1747
Overview
The
report states that the global market for orthobiologics will expand
at a 5.9% CAGR between 2013 and 2019. As such, the market, which had
a valuation of US$3.7 bn in 2012, will rise to US$5.5 bn by 2019.
The
report segments the global market for orthobiologics on the basis of
three broad criteria: product types, key applications, and key
regional markets. Based on the type of products, the market is
segmented into bone morphogenetic proteins, allografts,
viscosupplementation, synthetic bone substitutes, demineralized bone
matrix (DBM), stem cell therapy, and machined bones. Based on the key
applications of orthobiologics, the market is segmented into
reconstructive surgery, trauma, and spinal fusion. Key regions
studied in the report include Asia Pacific, Europe, North America,
and the Rest of the World (RoW).
Global
Orthobiologics Market: Key Companies
The
report presents a detailed overview of the competitive landscape of
the global orthobiologics market, wherein it studies the detailed
business profiles of some of the key businesses operating in the
market. Some of the key businesses operating in the market are
Alphatec Spine, Inc., Globus Medical, Inc., DePuy Synthes, Inc.,
Bacterin International, Inc., Medtronic, Inc., Integra LifeSciences
Corporation, Zimmer Holdings, Inc., Exactech, Inc., and Biomet, Inc.
Browse
Full Research
Report:
http://www.transparencymarketresearch.com/orthobiologics-market.html
http://www.transparencymarketresearch.com/orthobiologics-market.html
About
Us
Transparency
Market Research (TMR) is a market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We have an
experienced team of Analysts, Researchers, and Consultants, who us e
proprietary data sources and various tools and techniques to gather,
and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to
sustain a competitive edge.
Each
TMR Syndicated Research report covers a different sector – such as
pharmaceuticals, chemical, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
our syndicated reports thrive to provide clients to serve their
overall research requirement.
Contact
Transparency
Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/
No comments:
Post a Comment